Table 2.
Median survival in days and 1-,3-, 6-, and 12-month mortality for various diagnostic groups, n=191
| Mortality (%) | |||||
|---|---|---|---|---|---|
| Median survival in days (95% CI) | Days | ||||
| 30 | 90 | 180 | 365 | ||
| Dementia (n=16) | 244 (49–439) | 25 | 37 | 37 | 58 |
| Mb Parkinson (n=11) | 233 (0–660) | 9 | 18 | 36 | 55 |
| Miscellaneous (n=19) | 130 (45–215) | 17 | 39 | 61 | 61 |
| Stroke (n=95) | 119 (15–223) | 22 | 46 | 55 | 67 |
| Malignant obstruction (n=31) | 106 (63–149) | 23 | 42 | 68 | 77 |
| Other neurological diseases (n=13) | 75 (15–135) | 23 | 54 | 62 | 77 |
| Other malignancy (n=4) | — | — | — | — | — |
| No data available (n=2) | — | — | — | — | — |
| All patients (n=191) | 123 (74–172) | 22 | 42 | 56 | 67 |